Rubicon OrganicsROMJF -0.49%52 PB Ratio is 0.72 as of Jun. 24, 2026, which is 41% below its 10-year median of 1.22. GuruFocus rates ROMJF with a GF Score™ of 52/100 and a GF Value™ of $0.37 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 922 Drug Manufacturers companies, Rubicon Organics ranks better than 84.82% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-24), Rubicon Organics's share price is $0.3217. Rubicon Organics's Book Value per Share for the quarter that ended in Mar. 2026 was $0.45. Hence, Rubicon Organics's PB Ratio of today is 0.72.
The historical rank and industry rank for Rubicon Organics's PB Ratio or its related term are showing as below:
ROMJF'
s PB Ratio Range Over the Past 10 Years
Min: 0.5 Med: 1.22 Max: 7.98
Current: 0.73
During the past 10 years, Rubicon Organics's highest PB Ratio was 7.98. The lowest was 0.50. And the median was 1.22.
ROMJF's PB Ratio is ranked better than 84.82% of 922
companies
in the Drug Manufacturers industry
Industry Median: 1.88
vs ROMJF: 0.73
During the past 12 months, Rubicon Organics's average Book Value Per Share Growth Rate was -6.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -1.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 1.20% per year.
During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Rubicon Organics was 13.80% per year. The lowest was -1.60% per year. And the median was 5.10% per year.
Back to Basics: PB Ratio
Rubicon Organics (OTCPK:ROMJF) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Rubicon Organics PB Ratio Related Terms
Rubicon Organics PB Ratio Historical Data
* Premium members only.
The historical data trend for Rubicon Organics's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Rubicon Organics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rubicon Organics PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Rubicon Organics's PB Ratio distribution charts can be found below:
* The bar in red indicates where Rubicon Organics's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Rubicon Organics (ROMJF) has a PB Ratio of 0.72 as of Jun. 24, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Rubicon Organics and its competitors. This is 41% below median its historical median of 1.22. Over the past decade, Rubicon Organics' PB Ratio has ranged from 0.50 to 7.98. According to the industry distribution chart, Rubicon Organics ranks #140 out of 922 companies in the Drug Manufacturers industry, placing it in the top 15.2%.
Is Rubicon Organics' PB Ratio too high?
Rubicon Organics' current PB Ratio of 0.72 is 41% below median its 10-year median of 1.22. Over the past 10 years, this metric has ranged from a low of 0.50 to a high of 7.98. The Drug Manufacturers industry median PB Ratio is 1.88. Rubicon Organics' value of 0.72 is 61.7% below this industry median. Based on the distribution chart, Rubicon Organics ranks #140 out of 922 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Rubicon Organics has a GF Score™ of 52/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Rubicon Organics' PB Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Rubicon Organics ranks #140 out of 922 companies for PB Ratio. This places Rubicon Organics in the top 15% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.88. Rubicon Organics' value of 0.72 is 61.7% below this benchmark. Historically, Rubicon Organics' own PB Ratio has ranged from 0.50 to 7.98 over the past decade. While the company's 10-year median is 1.22 vs. the industry median of 1.88, Rubicon Organics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.88, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rubicon Organics's current PB Ratio of 0.72 is 61.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Rubicon Organics and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rubicon Organics's current PB Ratio is 0.72, which is 41% below median its own 10-year median of 1.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rubicon Organics stock overvalued right now?
Based on GuruFocus' analysis, Rubicon Organics (ROMJF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.37, compared to a current price of $0.32 — trading 13.1% below its estimated fair value. The current PB Ratio is 0.72, which is 41% below median its 10-year median of 1.22 and 61.7% below the Drug Manufacturers industry median of 1.88. Rubicon Organics' overall GF Score™ is 52/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Rubicon Organics (ROMJF), the current PB Ratio is 0.72 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rubicon Organics (ROMJF) Overvalued in 2026?
Based on GuruFocus' analysis, Rubicon Organics stock appears to be undervalued.
The current stock price of $0.32 is trading 13.1% below its estimated GF Value™ of $0.37.
GuruFocus considers Rubicon Organics to be Modestly Undervalued.
Key valuation signals for ROMJF:
PB Ratio: 0.72 (41% below median its 10-year median of 1.22)
GF Value™: $0.37 vs. price of $0.32 (13.1% below fair value)
Industry Position: 61.7% below the Drug Manufacturers median (#140 of 922)
No single metric tells the full story. See the ROMJF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rubicon Organics Inc is engaged in the production and sale of cannabis in Canada. The company produces and processes organic cannabis at its wholly owned, federally licensed 125,000 square foot facility in Delta, British Columbia which it sells under its wholly owned brands and certain wholesale channels. Its brands include Simply Bare, 1964 Supply Co, Wildflower, and Homestead Cannabis Supply. It operates in a single reportable segment, being the production and sale of cannabis in Canada.
52GF Score
Get the complete analysis for ROMJF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROMJF has been successfully added to your 
